Glucosamine has been prepared from shrimp processing waste. Shrimp processing waste is part of the non-meat organ consisting of the skin, head, antennae, and tail. This waste is obtained from the shrimp processing industry PT Ujung Timur in Sidoarjo, East Java - Indonesia. The preparation was carried out in four stages, namely (1) deproteination, (2) demineralization, (3) deacetylation, and (4) hydrolysis. The first stage (deproteination) aims to remove the protein contained in shrimp waste. The second stage (demineralization) aims to remove calcium carbonate and other minerals to produce chitin. Thus, this stage is to isolate chitin (poly N-acetyl glucosamine) from shrimp waste. The third stage (deacetylation) is to remove the acetyl group in chitin to produce chitosan. The fourth stage (hydrolysis) is to hydrolyze chitosan (poly glucosamine) into its monomer, namely glucosamine (2-amino-2-deoxy-D-glucose). The chitin yield was 31.25% by weight of the waste, and the glucosamine yield was 10.15%. Glucosamine preparation results are solid, yellowish-white (white bone) colored, with a melting point of 152-1550C. The compound is soluble in water, slightly soluble in acetone, and insoluble in chloroform. The glucosamine preparation results did not show its cytotoxic activity against P-388 murine leukemia cells.

1.
Iyan
and
Sari
D. A.
Barometer.
5
,
224
226
(
2020
)
2.
Rinaudo
M.
Prog Polym Sci.
31
,
603
632
(
2006
)
3.
Wandel
S.
,
Juni
P.
,
Tendal
B.
,
Nuesch
E.
,
Villiger
P. M.
,
Welton
N. J.
,
Reichanbach
S.
, and
Trelle
S.
BMJ.
341
,
c4675
(
2010
)
4.
Rodgers
M. R.
Int J Appl Res Vet Med.
4
,
155
162
(
2006
)
5.
Committe on the Framework for Evaluating the Safety of the Dietary Supplements NRC
.
Dietary supplements: a framework for evaluating safety
.
National Academies Press
. (
2005
)
6.
Bhathal
A.
,
Spryszak
M.
,
Louizos
C.
, and
Frankel
G.
Open Vet J.
7
,
36
49
(
2017
)
7.
Lubis
A. M. T.
,
Siagian
C.
,
Wonggokusuma
E.
,
Marsetyo
A. F.
, and
Setyohadi
B.
Acta Med Indones.
49
,
105
111
(
2017
).
8.
El-Sayed
S. T.
,
Omar
N. I.
,
El-Sayed
E. S. M.
, and
Shousha
W. G. J.
Appl Pharm Sci.
7
,
50
55
(
2017
)
9.
Zhu
X.
,
Wu
D.
,
Sang
L.
,
Wang
Y.
,
Shen
Y.
,
Zhuang
X.
,
Chu
M.
, and
Liang
J.
Clin Exp Rheumatol.
36
,
595
602
(
2018
)
10.
Kucharz
E. J.
,
Kovalenko
V.
,
Szántó
S.
,
Bruyère
O.
,
Cooper
C.
, and
Reginster
J-Y.
Curr Med Res Opin.
3
,
1
8
(
2016
)
11.
Božič
J.
,
Stoka
V.
, and
Dolenc
I.
PLOS ONE.
13
,
e0200757
(
2018
)
12.
13.
Moukarzel
W.
,
Fitremann
J.
,
Marty
J-D.
Nanoscale.
3
,
3285
3290
(
2011
)
14.
Wanichpongpan
P.
and
Attasat
S.
Int J Appl Sci Technol.
6
,
24
29
(
2016
)
15.
Alley
M. C.
,
Scudiero
D. A.
,
Monks
A.
,
Hursey
M.
,
Czerwinski
M. J.
,
Fine
D. L.
,
Abbott
B. J.
,
Mayo
J. G.
,
Shoemaker
R. H.
, and
Boyd
M. R.
Cancer Res.
48
,
589
601
(
1988
)
This content is only available via PDF.
You do not currently have access to this content.